SI9420008B - Postopek za izdelavo koncentrata anti-D imunoglobulina G in farmacevtski pripravek ,ki ga vsebuje - Google Patents

Postopek za izdelavo koncentrata anti-D imunoglobulina G in farmacevtski pripravek ,ki ga vsebuje Download PDF

Info

Publication number
SI9420008B
SI9420008B SI9420008A SI9420008A SI9420008B SI 9420008 B SI9420008 B SI 9420008B SI 9420008 A SI9420008 A SI 9420008A SI 9420008 A SI9420008 A SI 9420008A SI 9420008 B SI9420008 B SI 9420008B
Authority
SI
Slovenia
Prior art keywords
igg
plasma
adsorbent
process according
composition
Prior art date
Application number
SI9420008A
Other languages
English (en)
Slovenian (sl)
Other versions
SI9420008A (en
Inventor
Gerhard Hodler
Peter Lerch
Martin Stucki
Original Assignee
Rotkreuzstiftung Zentrallaboratorium Blutspendedienst Srk
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=8215103&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=SI9420008(B) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Rotkreuzstiftung Zentrallaboratorium Blutspendedienst Srk filed Critical Rotkreuzstiftung Zentrallaboratorium Blutspendedienst Srk
Publication of SI9420008A publication Critical patent/SI9420008A/sl
Publication of SI9420008B publication Critical patent/SI9420008B/sl

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/06—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies from serum
    • C07K16/065—Purification, fragmentation
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/06—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies from serum
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/34—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against blood group antigens

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Immunology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biochemistry (AREA)
  • Hematology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicinal Preparation (AREA)
SI9420008A 1993-12-27 1994-12-22 Postopek za izdelavo koncentrata anti-D imunoglobulina G in farmacevtski pripravek ,ki ga vsebuje SI9420008B (sl)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP93810912A EP0659767B2 (de) 1993-12-27 1993-12-27 Verfahren zur Herstellung eines Konzentrates von Anti-D-Immunoglobulin G und pharmazeutische Zusammensetzung, die dieses enthält
PCT/EP1994/004267 WO1995018155A1 (en) 1993-12-27 1994-12-22 Method of producing a concentrate of anti-d immunoglobulin g and pharmaceutical preparation which contains it

Publications (2)

Publication Number Publication Date
SI9420008A SI9420008A (en) 1996-02-29
SI9420008B true SI9420008B (sl) 1998-06-30

Family

ID=8215103

Family Applications (1)

Application Number Title Priority Date Filing Date
SI9420008A SI9420008B (sl) 1993-12-27 1994-12-22 Postopek za izdelavo koncentrata anti-D imunoglobulina G in farmacevtski pripravek ,ki ga vsebuje

Country Status (20)

Country Link
US (1) US5593675A (zh)
EP (1) EP0659767B2 (zh)
JP (1) JP2926463B2 (zh)
KR (1) KR100368563B1 (zh)
AT (1) ATE175979T1 (zh)
AU (1) AU682243B2 (zh)
CA (1) CA2138921C (zh)
CZ (1) CZ286271B6 (zh)
DE (1) DE59309332D1 (zh)
DK (1) DK0659767T4 (zh)
ES (1) ES2129076T5 (zh)
FI (1) FI112168B (zh)
GR (1) GR3029817T3 (zh)
HU (1) HU216864B (zh)
NO (1) NO315331B1 (zh)
NZ (1) NZ278057A (zh)
PL (1) PL180358B1 (zh)
SI (1) SI9420008B (zh)
TW (1) TW311884B (zh)
WO (1) WO1995018155A1 (zh)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1305896C (zh) * 1998-05-06 2007-03-21 基因技术股份有限公司 用离子交换层析纯化蛋白质
JP4685238B2 (ja) * 1998-06-09 2011-05-18 ツエー・エス・エル・ベーリング・アクチエンゲゼルシヤフト 静脈投与用免疫グロブリン及び他の免疫グロブリン生成物の製造法
DE19923027C2 (de) * 1999-05-19 2002-09-19 Aventis Behring Gmbh Verfahren zur Inaktivierung von Viren
US6475749B1 (en) 1999-08-11 2002-11-05 The Regents Of The University Of California Rh hybrid antibody
SE0001128D0 (sv) * 2000-03-30 2000-03-30 Amersham Pharm Biotech Ab A method of producing IgG
ES2184594B1 (es) * 2001-01-17 2004-01-01 Probitas Pharma Sa Procedimiento para la produccion de gammaglobulina g humana inactivada de virus.
EP1532983A1 (en) 2003-11-18 2005-05-25 ZLB Bioplasma AG Immunoglobulin preparations having increased stability
CA2458750C (en) 2004-02-23 2012-02-07 Bayer Inc. Isoolefin-diolefin production process and apparatus therefor
EP2221316A1 (en) * 2005-05-05 2010-08-25 Duke University Anti-CD19 antibody therapy for autoimmune disease
TWI320788B (en) 2005-05-25 2010-02-21 Hoffmann La Roche Method for the purification of antibodies
UA99263C2 (ru) * 2006-08-28 2012-08-10 Арес Трейдинг С.А. СПОСОБ ОЧИСТКИ Fc-СЛИТОГО БЕЛКА
EP2061803B2 (en) * 2006-08-28 2022-11-16 Ares Trading S.A. Process for the purification of fc-containing proteins
IT1397061B1 (it) * 2009-12-28 2012-12-28 Kedrion Spa Nuovo processo di purificazione su scala industriale di gammaglobuline da plasma umano per uso industriale.
EP2531218B1 (en) 2010-02-04 2018-12-12 CSL Behring AG Immunoglobulin preparation
EP2361636A1 (en) 2010-02-26 2011-08-31 CSL Behring AG Immunoglobulin preparation and storage system for an immunoglobulin preparation
RU2467783C2 (ru) * 2010-07-30 2012-11-27 Закрытое акционерное общество "БиоХимМак СТ" Способ хроматографического выделения иммуноглобулина
PL2616090T3 (pl) * 2010-09-17 2023-12-18 Takeda Pharmaceutical Company Limited Stabilizowanie immunoglobulin poprzez wodną formulację z histydyną o ph od słabo kwaśnego do obojętnego
TWI610937B (zh) * 2011-08-26 2018-01-11 巴克斯歐塔公司 用於降低血漿來源免疫球蛋白組成物之血栓性栓塞可能性的方法
AU2013203043B2 (en) 2013-03-15 2016-10-06 Takeda Pharmaceutical Company Limited Methods to produce a human plasma-derived igg preparation enriched in brain disease-related natural iggs
KR101917196B1 (ko) * 2014-03-11 2018-11-09 주식회사 녹십자홀딩스 면역글로불린의 정제방법
ES2769783T3 (es) * 2014-03-11 2020-06-29 Green Cross Holdings Corp Procedimiento de purificación de inmunoglobulina
EP4349859A1 (en) * 2023-01-27 2024-04-10 CSL Behring AG Method to purify anti-d immunoglobulin g from plasma

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3869436A (en) * 1971-06-01 1975-03-04 Statens Bakteriologiska Lab Method for fractionating plasma proteins using peg and ion-exchangers
EP0085747B2 (de) * 1982-02-08 1990-05-30 Schweizerisches Serum- und Impfinstitut und Institut zur Erforschung der Infektionskrankheiten Intravenös verabreichbares humanes Immunglobulin und Verfahren zu dessen Herstellung
US4434093A (en) * 1982-07-26 1984-02-28 Ortho Diagnostic Systems Inc. Methods for preparation of HBs Ag free gamma globulins
DE3640513A1 (de) * 1986-11-27 1988-06-09 Biotest Pharma Gmbh Verfahren zur herstellung eines virussicheren, lagerstabilen und intravenoes vertraeglichen immunglobulin-g-praeparates
US5118796A (en) * 1987-12-09 1992-06-02 Centocor, Incorporated Efficient large-scale purification of immunoglobulins and derivatives
US5138034A (en) * 1989-07-12 1992-08-11 The Green Cross Corporation Method of fractionating plasma proteins
US5177194A (en) * 1990-02-01 1993-01-05 Baxter International, Inc. Process for purifying immune serum globulins

Also Published As

Publication number Publication date
SI9420008A (en) 1996-02-29
EP0659767B2 (de) 2002-11-06
FI112168B (fi) 2003-11-14
PL180358B1 (pl) 2001-01-31
AU682243B2 (en) 1997-09-25
NO945032L (no) 1995-06-28
CA2138921C (en) 2004-11-02
ATE175979T1 (de) 1999-02-15
PL310435A1 (en) 1995-12-11
TW311884B (zh) 1997-08-01
ES2129076T5 (es) 2003-05-16
KR960701098A (ko) 1996-02-24
FI946103A0 (fi) 1994-12-27
EP0659767B1 (de) 1999-01-20
ES2129076T3 (es) 1999-06-01
DK0659767T4 (da) 2003-02-10
GR3029817T3 (en) 1999-06-30
AU1414395A (en) 1995-07-17
DE59309332D1 (de) 1999-03-04
CZ286271B6 (cs) 2000-03-15
HUT73376A (en) 1996-07-29
HU216864B (hu) 1999-09-28
US5593675A (en) 1997-01-14
NZ278057A (en) 1997-03-24
CZ249295A3 (en) 1996-01-17
WO1995018155A1 (en) 1995-07-06
KR100368563B1 (ko) 2003-04-03
JP2926463B2 (ja) 1999-07-28
EP0659767A1 (de) 1995-06-28
NO315331B1 (no) 2003-08-18
JPH07206708A (ja) 1995-08-08
FI946103A (fi) 1995-06-28
HU9502514D0 (en) 1995-11-28
NO945032D0 (no) 1994-12-23
CA2138921A1 (en) 1995-06-28
DK0659767T3 (da) 1999-09-13

Similar Documents

Publication Publication Date Title
SI9420008B (sl) Postopek za izdelavo koncentrata anti-D imunoglobulina G in farmacevtski pripravek ,ki ga vsebuje
CA2239237C (en) Chromatographic method for high yield purification and viral inactivation of antibodies
JP3094167B2 (ja) 免疫血清グロブリンの精製方法
RU2337109C2 (ru) ПРЕПАРАТ ИММУНОГЛОБУЛИНА IgG И СПОСОБ ЕГО ПОЛУЧЕНИЯ
RU2088590C1 (ru) Способ получения стандартизированного концентрата человеческого фактора виллебранда и концентрат, полученный этим способом
FI96210B (fi) Plasmaproteiinien kromatograafinen erottaminen
JP4445202B2 (ja) 治療的使用のためのヒト免疫グロブリン濃縮物の調製方法
CA2165203C (fr) Concentre d'immunoglobulines g a usage therapeutique et procede de production dudit concentre
CA2282843C (en) Purification of von willebrand factor by cation exchange chromatography
US5164487A (en) Manufacturing intravenous tolerable immunoglobulin-g preparation
CA3080108C (en) Improved method for purification of immunoglobulin
JP2019513119A (ja) 血液系物質からタンパク質を抽出する方法
EP0239565B1 (en) Method of separating proteins
CA2018511C (en) Process for the preparation of purified albumin solutions
CA2832665C (en) Method for producing injectable formulations of blood-derived protein materials, and materials obtained using said method
WO2008068455A1 (en) Protein purification
US7041798B1 (en) Method for the chromatographic fractionation of plasma or serum, preparations, so obtained, and their use
UA46005C2 (uk) Спосіб одержання фактора ix із біологічних джерел та фактор, одержаний вказаним способом
JP2551424B2 (ja) ＴＧＦ−β制御糖タンパク質サブユニツト
JPH04187700A (ja) アルブミン含有水溶液の精製法
CN115304668A (zh) 一种高效生产α1-抗胰蛋白酶的方法
JPS58121219A (ja) ヒト血液凝固第１０３因子の製造方法

Legal Events

Date Code Title Description
IF Valid on the event date
SP73 Change of data on owner

Owner name: ZLB BEHRING AG; CH

Effective date: 20050707

SP73 Change of data on owner

Owner name: CSL BEHRING AG; CH

Effective date: 20070913